Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/06/25 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/25 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/25 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/25 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/06/25 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/02/25 | Current report filing |
|
 |
5 | |
| 12/16/24 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 12/04/24 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 11/14/24 | Quarterly report pursuant to Section 13 or 15(d) |
|
|
54 | |
| 11/13/24 | Current report filing |
|
|
8 |